Sligo General Hospital
About Sligo General Hospital
Sligo University Hospital is an acute general hospital in Sligo, Ireland. It is managed by Saolta University Health Care Group.
There are 359 beds in Sligo General Hospital.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Cancer Trials Ireland
10
NSABP Foundation Inc
3
National Cancer Institute (NCI)
3
Queen Mary University of London
2
Alliance Foundation Trials, LLC.
1
Eli Lilly and Company
1
Health Service Executive, Ireland
1
Prostate Cancer Clinical Trials Consortium
1
Sligo General Hospital
1
Stemline Therapeutics, Inc.
1
University College Dublin
1
Clinical Trials at Sligo General Hospital
During the past decade, Sligo General Hospital conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 4 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Adjuvant Tamoxifen Compared With Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ
2003-09-01
2021-05-31
Completed
2,980
Anastrozole in Preventing Breast Cancer in Postmenopausal Women at Increased Risk of Breast Cancer
2003-09-01
2021-05-31
Completed
3,864
Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
2006-04-07
2030-09-30
Active, not recruiting
10,273
Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
2006-08-01
2023-12-01
Active, not recruiting
3,966
BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab
2008-04-01
2014-07-01
Terminated
3,509
Triamcinolone Versus Topical Treatment in Post Operative Phacoemulsification
2007-03-01
2008-04-01
Completed
150
A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer
2009-05-01
2018-02-01
Completed
1,613
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Sligo General Hospital" #1 sponsor was "Cancer Trials Ireland" with 10 trials, followed by "NSABP Foundation Inc" with 3 trials
sponsored, "National Cancer Institute (NCI)" with 3 trials sponsored, "Queen Mary University of London" with 2 trials sponsored and "Alliance Foundation Trials, LLC."
with 2 trials sponsored. Other sponsors include 2 different institutions and
companies that sponsored additional 12 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Sligo General Hospital"
#1 collaborator was "Genentech, Inc." with 2 trials as a collaborator, "NSABP Foundation Inc" with 2 trials as a collaborator, "American College of Surgeons" with 1 trials as a collaborator, "Austrian Breast & Colorectal Cancer Study Group" with 1 trials as a collaborator and "Breast International Group" with 1 trials as a collaborator. Other collaborators include 16 different institutions and companies that were
collaborators in the rest 26 trials.
Clinical Trials Conditions at Sligo General Hospital
According to Clinical.Site data, the most researched conditions in "Sligo General Hospital" are
"Breast Cancer" (13 trials), "Cancer" (2 trials), "Colorectal Cancer" (2 trials), "Metastatic Breast Cancer" (2 trials) and "Prostate Cancer" (2 trials). Many other conditions were trialed in "Sligo General Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Sligo General Hospital
Most popular intervention types in "Sligo General Hospital" are "Drug" (16 trials), "Other" (8 trials), "Biological" (2 trials), "Behavioral" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Anastrozole" (4 trials), "Letrozole" (4 trials), "Exemestane" (3 trials), "Laboratory Biomarker Analysis" (3 trials) and "Quality-of-Life Assessment" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Sligo General Hospital
The vast majority of trials in "Sligo General Hospital" are
15 trials for "Female" genders, 10 trials for "All" genders and 1 trials for "Male" genders.
Clinical Trials Status at Sligo General Hospital
Currently, there are NaN active trials in "Sligo General Hospital".
undefined are not yet recruiting,
3 are recruiting,
9 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 11 completed trials in Sligo General Hospital,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Sligo General Hospital, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 14 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".
Departments of Sligo General Hospital
Sligo General Hospital has several departments that took part in Clinical trials: "Galway Uni Hospital; Oncology Dept" - 7 trials
Departments List
Name
City
Trials